Advicenne SA Sustainability Reports

Advicenne S.A. is a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare renal diseases and neurological disorders.

Sector: Manufacturing

Country: France

Exchange: Euronext Paris

LEI: 969500YT5VMEYAYODW34

FIGI: BBG00G90MRK8

4 reports from 2021 to 2025

• Advicenne SA 2025 Universal Registration Document
• Advicenne SA 2023 Universal Registration Document
• Advicenne SA 2022 Universal Registration Document
• Advicenne SA 2021 Universal Registration Document